Range
4.35 - 4.63
Vol / Avg.
476K/8M
Div / Yield
-
52 Wk
1.86 - 9.54
Mkt Cap
190.5M
Payout Ratio
-
Open
4.47
P/E
-
EPS
-0.28
Shares
42.4M
Outstanding
42.4M
Total Float
29.5M
Sector: Health Care.Industry: Biotechnology
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-05
REV
Q2 2021Est.ActualSurprise
EPS-0.340-0.280 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Corvus Pharmaceuticals Questions & Anwsers

Q

How do I buy Corvus Pharmaceuticals (CRVS) stock?

A

You can purchase shares of Corvus Pharmaceuticals (NASDAQ: CRVS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Corvus Pharmaceuticals's (CRVS) competitors?

Q

What is the target price for Corvus Pharmaceuticals (CRVS) stock?

A

The latest price target for Corvus Pharmaceuticals (NASDAQ: CRVS) was reported by Mizuho on August 3, 2021. The analyst firm set a price target for 3.50 expecting CRVS to fall to within 12 months (a possible -22.05% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Corvus Pharmaceuticals (CRVS)?

A

The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $4.49 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

Does Corvus Pharmaceuticals (CRVS) pay a dividend?

A

There are no upcoming dividends for Corvus Pharmaceuticals.

Q

When is Corvus Pharmaceuticals (NASDAQ:CRVS) reporting earnings?

A

Corvus Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 5, 2021.

Q

Is Corvus Pharmaceuticals (CRVS) going to split?

A

There is no upcoming split for Corvus Pharmaceuticals.

Q

What sector and industry does Corvus Pharmaceuticals (CRVS) operate in?

A

Corvus Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.